NewslettersHematopoiesis NewsActivating Transcription Factor 4 in Erythroid Development and β-Thalassemia: A Powerful Regulator with Therapeutic PotentialBy Noshin Noorjahan - November 1, 20230111Recent research has suggested that activating transcription factor 4 contributes to decreased fetal hemoglobin level through its binding to potent negative regulators of HbF, such as BCL11A and MYB.[Annals of Hematology]Abstract